Laboratory Corporation of America Holdings (LH) : Analyst Rating Update

Laboratory Corporation of America Holdings (LH) has an average broker rating of 1.68, which is interpreted as a Buy, as rated by 17 equity analysts. Nonetheless, 10 analysts are positive on the stocks future and they recommend a Strong Buy on the stock. 2 other analysts advise a Buy. Nevertheless, the majority of 5 analysts consider that the stock is a Hold with neither a large upside nor a downside. Ranking by Zacks Investment Research for Coach Inc is 2, which is also a Buy.

Laboratory Corporation of America Holdings (LH) : 14 investment research analysts covering Laboratory Corporation of America Holdings (LH) have an average price target of $141.86 for the near short term. The highest target price given by the Brokerage Firm to the stock is $160 and the lowest target is $125 for the short term. Analysts expect the variance to be within $10.02 of the average price.

Laboratory Corporation of America Holdings (NYSE:LH): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $130.57 and $130.26 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $132.19. The buying momentum continued till the end and the stock did not give up its gains. It closed at $131.97, notching a gain of 0.95% for the day. The total traded volume was 801,832 . The stock had closed at $130.73 on the previous day.

Also, Major Brokerage house, Barclays maintains its ratings on Laboratory Corporation of America Holdings (NYSE:LH). In the latest research report, Barclays raises the target price from $152 per share to $155 per share. According to the latest information available, the shares are now rated Overweight by the analysts at the agency. The rating by the firm was issued on April 26, 2016. The company shares have rallied 10.76% from its 1 Year high price. On Jun 9, 2016, the shares registered one year high at $131.99 and the one year low was seen on Feb 8, 2016. The 50-Day Moving Average price is $128.38 and the 200 Day Moving Average price is recorded at $119.13.

Laboratory Corporation of America Holdings is an independent clinical laboratory company in the United States. Through a national network of laboratories, the Company offers a range of clinical laboratory tests that are used by the medical profession in core testing, patient diagnosis, and in the monitoring and treatment of disease. The Company manages its operations through two segments: the Clinical diagnostics laboratory segment, which includes core testing, as well as genomic and esoteric testing; and the Other segment, which consists of the Companys non-United States clinical diagnostic laboratory operations in Ontario, Canada. It also provides specialty testing services in the areas of allergy, clinical trials, diagnostic genetics, womens health, cardiovascular disease, identity, forensics, infectious disease, endocrinology, oncology, coagulation, occupational testing and pain management.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.